Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Depression Interview Article “MENTAL HEALTH IN TIMES OF COVID-19”: WORK FROM HOME, FINANCIAL WORRIES, FATIGUE. HOW TO COPE WITH STRESS CREATED BY COVID-19 Parkinson's Disease Article Early detection and treatment of Parkinson’s disease Schizophrenia Congress highlights Article Can people with ultra-high risk of psychosis benefit from cognitive remediation? Schizophrenia Bipolar Article Expanding Therapeutic Options and Developing Novel Long-Acting Injectables in Schizophrenia